World health organization

2010 in review: key health issues

A portrait of two boys, Burkina Faso.
WHO/A. Brunier

Meningitis vaccine in Burkina Faso

As many as 450 million people are at risk from meningococcal A disease, the primary cause of epidemic meningitis across Africa.

A new vaccine was developed by the Meningitis Vaccine Project. This is a partnership between WHO and PATH (an international NGO), with support from the Bill & Melinda Gates Foundation. The new vaccine, MenAfriVac, was introduced in Burkina Faso at the end of 2010. It promises to provide long-term protection for children as young as one year, at a price affordable for Africa.

© WHO. All rights reserved.